Efficacy and safety of intravenous vedolizumab treatment in Chinese patients with moderate-to-severe Crohn's disease

There were no new safety findings for vedolizumab treatment of Chinese patients with CD. Although the primary endpoint was not met, vedolizumab-treated patients showed improvements in other disease activity measures at Weeks 10 and 60.

Authors

Institutions

Publication Details

Journal
Clinics and Research in Hepatology and Gastroenterology
Published
2025-04-12
DOI
https://doi.org/10.1016/j.clinre.2025.102591
Citations
3
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
5.45
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of intravenous vedolizumab treatment in Chinese patients with moderate-to-severe Crohn's disease

Xiang Gao, Guillermo Rossiter, T Kitagawa, Lili Yang et al.
3 citations
Clinics and Research in Hepatology and Gastroenterology
Inflammatory Bowel Disease
5.45
article

Efficacy and safety of intravenous vedolizumab treatment in Chinese patients with moderate-to-severe Crohn's disease

Xiang Gao, Guillermo Rossiter, T Kitagawa, Lili Yang, Minhu Chen, Qian Cao, Yue Sun
article en
3 citations

Abstract

There were no new safety findings for vedolizumab treatment of Chinese patients with CD. Although the primary endpoint was not met, vedolizumab-treated patients showed improvements in other disease activity measures at Weeks 10 and 60.

Clinics and Research in Hepatology and GastroenterologyVol. 49(6)
Sun Yat-sen University (CN), Sir Run Run Shaw Hospital (CN), Sixth Affiliated Hospital of Sun Yat-sen University (CN), The First Affiliated Hospital, Sun Yat-sen University (CN), Takeda (United States) (US), Takeda (Japan) (JP), Zhejiang University (CN)
Good health and well-being
Openalex Percentile: Top 5%
Inflammatory Bowel Disease
5.45
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of intravenous vedolizumab treatment in Chinese patients with moderate-to-severe Crohn's disease — Xiang Gao, Guillermo Rossiter, et al. · Clinics and Research in Hepatology and Gastroenterology (2025) | TGRS Research Map | TGRS